Update: 06.08.2024
Last week: 30 week 2024 (22.07.2024 - 28.07.2024)
Last full month: June 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 588 | -2.5% | 13.5% | 0.2 | 14 481 980 | -2.7% | 9.8% | 0.1 | -3.6% |
| MoM | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| YTD | 217 079 | 19.5% | 11.4% | 2.6 | 469 962 937 | 40.4% | 9.4% | 2 | -7.7% |
| MAT | 376 214 | 24.7% | 10.5% | 2 | 792 074 904 | 43.4% | 8.8% | 1.5 | 1.6% |
| BRAINMAX | |||||||||
| WoW | 1 139 | 7.4% | 100.0% | 0 | 4 297 501 | 7.7% | 100.0% | 0 | 7.4% |
| MoM | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| YTD | 31 677 | 40.1% | 100.0% | 0 | 115 800 643 | 52.2% | 100.0% | 0 | 40.1% |
| MAT | 55 724 | 70.4% | 100.0% | 0 | 200 725 231 | 85.0% | 100.0% | 0 | 70.4% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 649 | -4.6% | 46.2% | 0.1 | 45 914 477 | -3.8% | 37.9% | -0.2 | -4.8% |
| MoM | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| YTD | 510 716 | -3.8% | 44.9% | 0.9 | 1 610 503 341 | -0.4% | 36.7% | -2.7 | -5.8% |
| MAT | 848 679 | 4.3% | 45.5% | 1.1 | 2 685 201 673 | 10.8% | 38.0% | -1.5 | 1.8% |
| MIGRENIUM | |||||||||
| WoW | 9 833 | -4.8% | 0.4% | 0 | 3 325 385 | -4.1% | 0.6% | 0 | -0.2% |
| MoM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| YTD | 352 966 | -5.3% | 0.5% | -0.1 | 108 666 920 | 60.9% | 0.7% | 0.2 | 10.2% |
| MAT | 621 970 | -3.8% | 0.5% | -0.1 | 163 773 078 | 39.6% | 0.6% | 0.1 | 13.8% |
| MODELAX-N | |||||||||
| WoW | 23 083 | -1.0% | 18.7% | -0.3 | 10 805 684 | -0.2% | 12.7% | -0.2 | 0.7% |
| MoM | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| YTD | 889 692 | 36.4% | 23.2% | 4.3 | 381 245 488 | 85.8% | 14.9% | 4.4 | 10.8% |
| MAT | 1 405 183 | 60.8% | 21.1% | 5.7 | 558 818 110 | 99.4% | 13.0% | 4.2 | 17.7% |
| REDUXIN | |||||||||
| WoW | 10 600 | -4.4% | 33.4% | 0.1 | 55 068 683 | -2.0% | 45.5% | 0.6 | -4.8% |
| MoM | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| YTD | 374 715 | -8.4% | 32.9% | -0.9 | 2 011 995 844 | 15.4% | 45.8% | 3.4 | -5.8% |
| MAT | 603 631 | -3.5% | 32.4% | -1.8 | 3 141 839 059 | 19.6% | 44.4% | 1.7 | 1.8% |
| REDUXIN FORTE | |||||||||
| WoW | 2 922 | -4.6% | 9.2% | 0 | 12 264 652 | -4.8% | 10.1% | -0.2 | -4.8% |
| MoM | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| YTD | 99 910 | 0.5% | 8.8% | 0.6 | 433 194 848 | 14.9% | 9.9% | 0.7 | -5.8% |
| MAT | 166 501 | 13.0% | 8.9% | 0.9 | 709 529 461 | 26.1% | 10.0% | 0.9 | 1.8% |
| SALVISAR | |||||||||
| WoW | 7 941 | -1.0% | 1.1% | 0 | 3 552 417 | -1.1% | 1.1% | 0 | 0.2% |
| MoM | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
| YTD | 303 184 | 1.7% | 1.4% | 0 | 122 965 008 | 27.0% | 1.2% | 0.1 | -0.9% |
| MAT | 503 494 | -12.2% | 1.3% | -0.2 | 189 908 601 | -1.5% | 1.1% | -0.2 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 217 079 | 19.5% | 11.4% | 2.6 | 469 962 937 | 40.4% | 9.4% | 2 | -7.7% |
| BRAINMAX | 31 677 | 40.1% | 100.0% | 0 | 115 800 643 | 52.2% | 100.0% | 0 | 40.1% |
| GOLDLINE PLUS | 510 716 | -3.8% | 44.9% | 0.9 | 1 610 503 341 | -0.4% | 36.7% | -2.7 | -5.8% |
| MIGRENIUM | 352 966 | -5.3% | 0.5% | -0.1 | 108 666 920 | 60.9% | 0.7% | 0.2 | 10.2% |
| MODELAX-N | 889 692 | 36.4% | 23.2% | 4.3 | 381 245 488 | 85.8% | 14.9% | 4.4 | 10.8% |
| REDUXIN CAPS | 374 715 | -8.4% | 32.9% | -0.9 | 2 011 995 844 | 15.4% | 45.8% | 3.4 | -5.8% |
| REDUXIN FORTE | 99 910 | 0.5% | 8.8% | 0.6 | 433 194 848 | 14.9% | 9.9% | 0.7 | -5.8% |
| SALVISAR | 303 184 | 1.7% | 1.4% | 0 | 122 965 008 | 27.0% | 1.2% | 0.1 | -0.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 376 214 | 24.7% | 10.5% | 2 | 792 074 904 | 43.4% | 8.8% | 1.5 | 1.6% |
| BRAINMAX | 55 724 | 70.4% | 100.0% | 0 | 200 725 231 | 85.0% | 100.0% | 0 | 70.4% |
| GOLDLINE PLUS | 848 679 | 4.3% | 45.5% | 1.1 | 2 685 201 673 | 10.8% | 38.0% | -1.5 | 1.8% |
| MIGRENIUM | 621 970 | -3.8% | 0.5% | -0.1 | 163 773 078 | 39.6% | 0.6% | 0.1 | 13.8% |
| MODELAX-N | 1 405 183 | 60.8% | 21.1% | 5.7 | 558 818 110 | 99.4% | 13.0% | 4.2 | 17.7% |
| REDUXIN CAPS | 603 631 | -3.5% | 32.4% | -1.8 | 3 141 839 059 | 19.6% | 44.4% | 1.7 | 1.8% |
| REDUXIN FORTE | 166 501 | 13.0% | 8.9% | 0.9 | 709 529 461 | 26.1% | 10.0% | 0.9 | 1.8% |
| SALVISAR | 503 494 | -12.2% | 1.3% | -0.2 | 189 908 601 | -1.5% | 1.1% | -0.2 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 588 | -2.5% | 13.5% | 0.2 | 14 481 980 | -2.7% | 9.8% | 0.1 | -3.6% |
| BRAINMAX | 1 139 | 7.4% | 100.0% | 0 | 4 297 501 | 7.7% | 100.0% | 0 | 7.4% |
| GOLDLINE PLUS | 14 649 | -4.6% | 46.2% | 0.1 | 45 914 477 | -3.8% | 37.9% | -0.2 | -4.8% |
| MIGRENIUM | 9 833 | -4.8% | 0.4% | 0 | 3 325 385 | -4.1% | 0.6% | 0 | -0.2% |
| MODELAX-N | 23 083 | -1.0% | 18.7% | -0.3 | 10 805 684 | -0.2% | 12.7% | -0.2 | 0.7% |
| REDUXIN CAPS | 10 600 | -4.4% | 33.4% | 0.1 | 55 068 683 | -2.0% | 45.5% | 0.6 | -4.8% |
| REDUXIN FORTE | 2 922 | -4.6% | 9.2% | 0 | 12 264 652 | -4.8% | 10.1% | -0.2 | -4.8% |
| SALVISAR | 7 941 | -1.0% | 1.1% | 0 | 3 552 417 | -1.1% | 1.1% | 0 | 0.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| BRAINMAX | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| GOLDLINE PLUS | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| MIGRENIUM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| MODELAX-N | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| REDUXIN CAPS | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| REDUXIN FORTE | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| SALVISAR | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs